Featured Research

from universities, journals, and other organizations

Gamma Knife Treatment For Glioblastomas Shows Promising Results

Date:
November 3, 2009
Source:
University Hospitals Case Medical Center
Summary:
Researchers report promising results from a cutting-edge research study that treated the aggressive brain tumors glioblastoma multiforme using a novel type of imaging called MR spectroscopy coupled with high dose radiation in the form of Gamma Knife radiosurgery. Patients' survival rates increased by almost four months (3.7 months) compared with patients who were treated with traditional conventional radiotherapy alone.

Researchers from University Hospitals Case Medical Center report promising results from a cutting-edge research study that treated the aggressive brain tumors glioblastoma multiforme (GBM) using a novel type of imaging called MR spectroscopy coupled with high dose radiation in the form of Gamma Knife radiosurgery.

Patients' survival rates increased by almost four months (3.7 months) compared with patients who were treated with traditional conventional radiotherapy alone.

"The four month increase is quite significant as the median survival of patients treated with conventional radiotherapy alone is only one year," said Douglas B. Einstein, M.D., Ph.D., lead author of the study and Vice Chairman and Clinical Director of the Department of Radiation Oncology at University Hospitals Case Medical Center and Assistant Professor at Case Western Reserve University School of Medicine.

The results of this study were presented at the American Society for Radiation Oncology (ASTRO) meeting in Chicago on Nov. 2, 2009.

GBM is the most common and aggressive type of brain cancer, and is notorious for growing back within months of surgery. It is the type of cancer that the late Sen. Edward Kennedy battled.

Thirty-five patients were enrolled in this Phase II, five-year study. Patients underwent MR spectroscopy imaging to non-invasively identify regions of the GBM tumor that were more aggressive than other areas. These regions were then targeted with high-dose radiation from a Gamma Knife. Treatment was then followed by standard conventional radiotherapy.

The Gamma Knife is an instrument that allows physicians to perform radiosurgery, a non-invasive neurosurgical procedure that uses powerful doses of radiation to target and treat diseased brain tissue while leaving surrounding tissue intact. The state-of-the art technology allows physicians to operate on brain lesions often considered inoperable.

MR spectroscopy involves a specialized MR scan where peaks of metabolic compounds can be identified and quantitated within the MR image. These peaks include choline which is elevated in areas of the MR image that have a high cell turnover such as an active brain tumor and NAA found in neuronal tissue and used to separate normal neuronal cells from the glioma brain tumor cells.

Given the positive finding from this study, a multi-center Phase III randomized trial is being designed, said Dr. Einstein.


Story Source:

The above story is based on materials provided by University Hospitals Case Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

University Hospitals Case Medical Center. "Gamma Knife Treatment For Glioblastomas Shows Promising Results." ScienceDaily. ScienceDaily, 3 November 2009. <www.sciencedaily.com/releases/2009/11/091102171223.htm>.
University Hospitals Case Medical Center. (2009, November 3). Gamma Knife Treatment For Glioblastomas Shows Promising Results. ScienceDaily. Retrieved October 22, 2014 from www.sciencedaily.com/releases/2009/11/091102171223.htm
University Hospitals Case Medical Center. "Gamma Knife Treatment For Glioblastomas Shows Promising Results." ScienceDaily. www.sciencedaily.com/releases/2009/11/091102171223.htm (accessed October 22, 2014).

Share This



More Health & Medicine News

Wednesday, October 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

CDC Revamps Ebola Guidelines After Criticism

CDC Revamps Ebola Guidelines After Criticism

Newsy (Oct. 21, 2014) The Centers for Disease Control and Prevention have issued new protocols for healthcare workers interacting with Ebola patients. Video provided by Newsy
Powered by NewsLook.com
WHO: Ebola Vaccine Trials to Start a in January

WHO: Ebola Vaccine Trials to Start a in January

AP (Oct. 21, 2014) Tens of thousands of doses of experimental Ebola vaccines could be available for "real-world" testing in West Africa as soon as January as long as they are deemed safe in soon to start trials, the World Health Organization said Tuesday. (Oct. 21) Video provided by AP
Powered by NewsLook.com
First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

Newsy (Oct. 21, 2014) A medical team has for the first time given a man the ability to walk again after transplanting cells from his brain onto his severed spinal cord. Video provided by Newsy
Powered by NewsLook.com
CDC Issues New Ebola Guidelines for Health Workers

CDC Issues New Ebola Guidelines for Health Workers

Reuters - US Online Video (Oct. 21, 2014) The U.S. Centers for Disease Control and Prevention has set up new guidelines for health workers taking care of patients infected with Ebola. Linda So reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins